GeneDx Holdings Corp. Amortization of Debt Issuance Costs
GeneDx Holdings Corp. (WGS) reported Amortization of Debt Issuance Costs of $387.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2023-11-03
- GeneDx Holdings Corp. amortization of debt issuance costs for the quarter ending 2023-09-30 was $130.00K, a 0.00% change year-over-year.
- GeneDx Holdings Corp. amortization of debt issuance costs for the quarter ending 2023-06-30 was $129.00K, a 0.00% change year-over-year.
- GeneDx Holdings Corp. amortization of debt issuance costs for the quarter ending 2023-03-31 was $128.00K, a 0.00% change year-over-year.
- GeneDx Holdings Corp. amortization of debt issuance costs for the quarter ending 2022-12-31 was $131.00K, a 98.48% increase year-over-year.
- GeneDx Holdings Corp. amortization of debt issuance costs for fiscal 2022 was $518.00K, a 684.85% increase from fiscal 2021.
- GeneDx Holdings Corp. amortization of debt issuance costs for fiscal 2021 was $66.00K.
- GeneDx Holdings Corp. amortization of debt issuance costs for fiscal 2020 was $0.00.
- GeneDx Holdings Corp. amortization of debt issuance costs for fiscal 2019 was $0.00.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $259.00K derived: sum of 2 quarters · filed 2023-11-03 | $387.00K 10-Q · filed 2023-11-03 | $518.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $257.00K 10-Q · filed 2023-08-08 | $388.00K derived: sum of 3 quarters · filed 2023-08-08 | $518.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-03-31 | $128.00K 10-Q · filed 2023-05-09 | $259.00K derived: sum of 2 quarters · filed 2023-05-09 | $389.00K derived: sum of 3 quarters · filed 2023-11-03 | $518.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $261.00K derived: sum of 2 quarters · filed 2023-11-03 | $390.00K derived: sum of 3 quarters · filed 2023-11-03 | $518.00K 10-K · filed 2023-03-16 |
| 2022-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $259.00K derived: sum of 2 quarters · filed 2023-11-03 | $387.00K 10-Q · filed 2023-11-03 | $453.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $257.00K 10-Q · filed 2023-08-08 | $323.00K derived: sum of 3 quarters · filed 2023-08-08 | $323.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $128.00K 10-Q · filed 2023-05-09 | $194.00K derived: sum of 2 quarters · filed 2023-05-09 | $194.00K derived: sum of 3 quarters · filed 2023-05-09 | $194.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $66.00K derived: sum of 2 quarters · filed 2023-03-16 | $66.00K derived: sum of 3 quarters · filed 2023-03-16 | $66.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-16 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |